FIRST WAVE BIOPHARMA
First Wave BioPharma, Inc. is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company has a pipeline of three gut-restricted GI assets. The lead therapeutic candidate is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis, currently in two Phase 2 clinical trials. AzurRx is launching two clinical programs in 2021 using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor, FW-1022 for COVID-19 gastrointestinal infections, and FW-420 for grade 1 Immune Checkpoint Inhibitor-Associated Colitis and diarrhea in oncology patients.
FIRST WAVE BIOPHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Brooklyn, New York, United States
Country:
United States
Website Url:
http://www.azurrx.com
Total Employee:
1+
Status:
Active
Contact:
(646)699-7855
Email Addresses:
[email protected]
Total Funding:
49.32 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS Pound Sterling AWS Global Accelerator KnowBe4
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-09-16 | First Wave Bio | First Wave Bio acquired by First Wave BioPharma | 229 M USD |
Investors List
Alexander Capital
Alexander Capital investment in Post-IPO Equity - First Wave BioPharma
Official Site Inspections
http://www.azurrx.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "First Wave BioPharma"
AzurX
Our expertise. IN-DEPTH INDUSTRY KNOWLEDGE AND RELATIONSHIPS AzurX works with a diverse portfolio of space and advanced technology …See details»
AzurX - Crunchbase Investor Profile & Investments
AzurX is a UAE-based investment and strategic space firm committed to advancing the state of humanity and human knowledge. AzurX is the trusted …See details»
AzurX | Space & Strategic Technologies - LinkedIn
AzurX is an innovation and strategic space firm committed to advancing the state of humanity and human knowledge. | AzurX was founded at the dawn of the …See details»
AzurX - teaserclub.com
AzurX serves as a strategic advisor to a diverse range of influential businesses and institutions, aiming to enhance human knowledge and advance societal progress. Through its investments …See details»
AzurX | Space & Strategic Technologies - SignalHire
AzurX is the trusted advisor and counselor to a growing number of the world's most inf... AzurX is an innovation and strategic space firm committed to advancing the state of humanity and …See details»
AzurX Space Ventures - Crunchbase Investor Profile
Aug 21, 2024 Sub-Organization of . AzurX . Founded Date 2024; Founders Anna Hazlett; Operating Status Active; Investor Type Family Investment …See details»
AzurX
As a Partner at AzurX, John’s focus is space, cyber, Web3, and other strategic technologies and their critical roles in developing economies and accessing …See details»
AzurRx BioPharma Announces Acquisition of First Wave Bio and its ...
Sep 13, 2021 AzurRx BioPharma to be renamed “First Wave BioPharma” and trade under new NASDAQ ticker symbol, “FWBI” Three IBD clinical indications, including ulcerative colitis and …See details»
Anna Hazlett | The Global Aerospace Summit
Anna Hazlett is the founder of AzurX, a leading entity in the Middle East's private space and satellite consulting services and investment arena. Under her visionary leadership, AzurX …See details»
AzurRx BioPharma - VentureRadar
Website: http://azurrx.com. Develops targeted, non-systemic therapies for gastrointestinal diseases, focusing on recombinant lipase treatments and proprietary ...See details»
AzurRx BioPharma Inc. (NASDAQ: AZRX) is “One to Watch”
Oct 15, 2020 AzurRx BioPharma’s lead therapeutic, MS1819, is a recombinant lipase treatment for exocrine pancreatic insufficiency and is currently targeting patients with cystic fibrosis and …See details»
AzurX - Investments, Portfolio & Company Exits - Crunchbase
Experience the new Crunchbase, powered by AI . Investment Firm. AzurXSee details»
AzurX
STRATEGIC TECHNOLOGIES We support the development and growth of early-stage through to late-stage hard tech companies focused on space and strategic technologies.. From Artificial …See details»
AzurX - Contacts, Employees, Board Members, Advisors & Alumni
Experience the new Crunchbase, powered by AI . Investment Firm. AzurXSee details»
AzurRx BioPharma Completes Initial Cohort Enrollment into
BOCA RATON, Fla., Aug. 12, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted, …See details»
AzurRx BioPharma to Change Corporate Name to First Wave …
Company to begin trading on Nasdaq under new ticker symbol, “FWBI”, effective September 22. BOCA RATON, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. …See details»
AzurX
AzurX collaborates and co-invests with strategic investment funds, as well as place direct investments in visionary founders and growth-stage ventures embedded in the space sector - …See details»
AzurRx BioPharma CEO Issues Letter to Shareholders Regarding …
BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage …See details»
AzurRx BioPharma 2025 Company Profile: Valuation, Investors
AzurRx BioPharma General Information Description. First Wave BioPharma Inc is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic …See details»
Office of Public Affairs | CEO of Health Care Software Company ...
4 days ago Note: this release has been updated to include a quote from the U.S. Attorney for the Southern District of Florida. A federal jury convicted the CEO of Power Mobility Doctor Rx, …See details»